D-1103-2023 Class III
Recall Details
- Product Type
- Drugs
- Report Date
- August 30, 2023
- Initiation Date
- August 14, 2023
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 13,502 vials
Product Description
Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.
Reason for Recall
Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.
Distribution Pattern
Nationwide in the U.S.A.
Code Information
Lots: 3A004A, 3A004B, Exp 12/31/2024; 3B005A, Exp 1/31/2025